Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 10, 2015 9:25am EDT

OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient Adults

Jul 10, 2015 9:00am EDT

OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources

Jul 02, 2015 11:10am EDT

OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition

Jul 01, 2015 8:57am EDT

Conversion Right Extended on OPKO 3.0% Convertible Senior Notes

Jun 26, 2015 10:25am EDT

OPKO 4Kscore® Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

Jun 09, 2015 11:54am EDT

OPKO to Present New Data at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress on Its Long-Acting Clotting Factor VIIa

Jun 08, 2015 8:00am EDT

OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss Merger

May 29, 2015 2:42pm EDT

OPKO Announces Submission of Rayaldee™ New Drug Application to U.S. Food and Drug Administration

May 27, 2015 10:54am EDT

OPKO Health to Present at the Jefferies 2015 Healthcare Conference

May 18, 2015 9:21am EDT

OPKO Announces 4Kscore® Abstracts at the 2015 American Urological Association (AUA) Annual Meeting

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap